{[ promptMessage ]}

Bookmark it

{[ promptMessage ]}

3A-W'08-EX#3 PRACTICE-SOLUTIONS

3A-W'08-EX#3 PRACTICE-SOLUTIONS - ECON...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
ECON 3A-W’08-EXAM#3(FINAL)-SOLUTIONS TO PRACTICE PROBLEMS P 1 FINANCIAL ANALYSIS USING F/S OF PFIZER 1. Ratio computations –– See attached Excel worksheets FORMATTING IS IMPORTANT (PRECISION, EXPRESSION AS PERCENTAGES, ETC). FOLLOW WHAT WAS DEMONSTRATED IN CLASS. 2. Is Pfizer able to meet its current obligations? Cite relevant ratios. Yes. Pfizer’s liquidity ratios are all strong and improving or at least relatively consistent. The dollar amount of working capital increased and the current ratio was steady. The cash debt coverage decreased, but is well above the .40 “healthly” ratio. The cash to cash operating cycle seems long, but has improved. Would you walk to the mailbox with confidence on interest payment dates if you were a holder of Pfizer’s long-term debt? Cite relevant ratios. Yes. There is a strong equity cushion in both years of over 50% (complement of debt to equity ratio), cash debt coverage is consistent and is over the .20 healthy mark. Times interest earned decreased, but is very strong—well over the danger mark of 2.00.
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full Document Right Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

{[ snackBarMessage ]}